BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11597939)

  • 1. Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels.
    Morton RE; Nunes V; Izem L; Quintão E
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1642-9. PubMed ID: 11597939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
    Serdyuk AP; Morton RE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids.
    Morton RE; Greene DJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3041-8. PubMed ID: 9409291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP).
    Paromov VM; Morton RE
    J Biol Chem; 2003 Oct; 278(42):40859-66. PubMed ID: 12907677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity of various non-esterified fatty acids to suppress lipid transfer inhibitor protein activity is related to their perturbation of the lipoprotein surface.
    Morton RE; Greene DJ
    Biochim Biophys Acta; 2000 Jul; 1486(2-3):275-84. PubMed ID: 10903478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.
    Wang X; Driscoll DM; Morton RE
    J Biol Chem; 1999 Jan; 274(3):1814-20. PubMed ID: 9880564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.
    McPherson R; Mann CJ; Tall AR; Hogue M; Martin L; Milne RW; Marcel YL
    Arterioscler Thromb; 1991; 11(4):797-804. PubMed ID: 2065034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects.
    Morton RE; Gnizak HM; Greene DJ; Cho KH; Paromov VM
    J Lipid Res; 2008 Jan; 49(1):127-35. PubMed ID: 17901467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex.
    He Y; Greene DJ; Kinter M; Morton RE
    J Lipid Res; 2008 Jul; 49(7):1529-37. PubMed ID: 18369235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia.
    Izem L; Morton RE
    J Lipid Res; 2009 Apr; 50(4):676-84. PubMed ID: 19008550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL.
    Morton RE; Greene DJ
    J Lipid Res; 2003 Dec; 44(12):2287-96. PubMed ID: 12951364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
    Korhonen T; Hannuksela ML; Seppänen S; Kervinen K; Kesäniemi YA; Savolainen MJ
    Eur J Clin Pharmacol; 1999 Feb; 54(12):903-10. PubMed ID: 10192749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states.
    Lottenberg AM; Nunes VS; Lottenberg SA; Shimabukuro AF; Carrilho AJ; Malagutti S; Nakandakare ER; McPherson R; Quintão EC
    Atherosclerosis; 1996 Oct; 126(2):265-75. PubMed ID: 8902152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer in hypercholesterolaemia: fasting and postprandial studies with and without pravastatin.
    Contacos C; Barter PJ; Vrga L; Sullivan DR
    Atherosclerosis; 1998 Nov; 141(1):87-98. PubMed ID: 9863541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes.
    Morton RE; Greene DJ
    J Lipid Res; 1994 May; 35(5):836-47. PubMed ID: 8071606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.
    Morton RE; Greene DJ
    J Lipid Res; 2011 Dec; 52(12):2262-2271. PubMed ID: 21937674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.